×
S&P 500   3,866.82 (+0.92%)
DOW   31,193.20 (+0.73%)
QQQ   290.13 (+1.10%)
AAPL   143.59 (+1.43%)
MSFT   267.26 (+1.68%)
META   171.01 (+1.68%)
GOOGL   2,301.58 (+1.60%)
AMZN   115.07 (+1.38%)
TSLA   697.24 (-0.28%)
NVDA   152.52 (+1.92%)
NIO   20.72 (-6.58%)
BABA   119.44 (-0.57%)
AMD   75.82 (+0.82%)
MU   57.90 (+2.06%)
CGC   2.68 (-1.11%)
T   21.14 (-0.14%)
GE   61.82 (-0.34%)
F   11.15 (-0.45%)
DIS   96.52 (-0.68%)
AMC   12.46 (-2.50%)
PFE   52.69 (+2.03%)
PYPL   73.74 (-0.89%)
NFLX   185.34 (-0.29%)
S&P 500   3,866.82 (+0.92%)
DOW   31,193.20 (+0.73%)
QQQ   290.13 (+1.10%)
AAPL   143.59 (+1.43%)
MSFT   267.26 (+1.68%)
META   171.01 (+1.68%)
GOOGL   2,301.58 (+1.60%)
AMZN   115.07 (+1.38%)
TSLA   697.24 (-0.28%)
NVDA   152.52 (+1.92%)
NIO   20.72 (-6.58%)
BABA   119.44 (-0.57%)
AMD   75.82 (+0.82%)
MU   57.90 (+2.06%)
CGC   2.68 (-1.11%)
T   21.14 (-0.14%)
GE   61.82 (-0.34%)
F   11.15 (-0.45%)
DIS   96.52 (-0.68%)
AMC   12.46 (-2.50%)
PFE   52.69 (+2.03%)
PYPL   73.74 (-0.89%)
NFLX   185.34 (-0.29%)
S&P 500   3,866.82 (+0.92%)
DOW   31,193.20 (+0.73%)
QQQ   290.13 (+1.10%)
AAPL   143.59 (+1.43%)
MSFT   267.26 (+1.68%)
META   171.01 (+1.68%)
GOOGL   2,301.58 (+1.60%)
AMZN   115.07 (+1.38%)
TSLA   697.24 (-0.28%)
NVDA   152.52 (+1.92%)
NIO   20.72 (-6.58%)
BABA   119.44 (-0.57%)
AMD   75.82 (+0.82%)
MU   57.90 (+2.06%)
CGC   2.68 (-1.11%)
T   21.14 (-0.14%)
GE   61.82 (-0.34%)
F   11.15 (-0.45%)
DIS   96.52 (-0.68%)
AMC   12.46 (-2.50%)
PFE   52.69 (+2.03%)
PYPL   73.74 (-0.89%)
NFLX   185.34 (-0.29%)
S&P 500   3,866.82 (+0.92%)
DOW   31,193.20 (+0.73%)
QQQ   290.13 (+1.10%)
AAPL   143.59 (+1.43%)
MSFT   267.26 (+1.68%)
META   171.01 (+1.68%)
GOOGL   2,301.58 (+1.60%)
AMZN   115.07 (+1.38%)
TSLA   697.24 (-0.28%)
NVDA   152.52 (+1.92%)
NIO   20.72 (-6.58%)
BABA   119.44 (-0.57%)
AMD   75.82 (+0.82%)
MU   57.90 (+2.06%)
CGC   2.68 (-1.11%)
T   21.14 (-0.14%)
GE   61.82 (-0.34%)
F   11.15 (-0.45%)
DIS   96.52 (-0.68%)
AMC   12.46 (-2.50%)
PFE   52.69 (+2.03%)
PYPL   73.74 (-0.89%)
NFLX   185.34 (-0.29%)
NASDAQ:ALGN

Align Technology Stock Forecast, Price & News

$252.57
-1.54 (-0.61%)
(As of 07/6/2022 03:22 PM ET)
Add
Compare
Today's Range
$247.46
$255.83
50-Day Range
$229.82
$360.43
52-Week Range
$225.86
$737.45
Volume
22,368 shs
Average Volume
1.10 million shs
Market Capitalization
$19.91 billion
P/E Ratio
28.41
Dividend Yield
N/A
Price Target
$586.20

Align Technology MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
135.2% Upside
$586.20 Price Target
Short Interest
Healthy
3.11% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.34
Upright™ Environmental Score
News Sentiment
1.16mentions of Align Technology in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$2.26 M Bought Last Quarter
Proj. Earnings Growth
31.22%
From $9.00 to $11.81 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

3.10 out of 5 stars

Medical Sector

25th out of 1,426 stocks

Surgical Appliances & Supplies Industry

2nd out of 30 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive ALGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Align Technology and its competitors with MarketBeat's FREE daily newsletter.

Align Technology logo

About Align Technology (NASDAQ:ALGN) Stock

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

ALGN Stock News Headlines

ALGN August 12th Options Begin Trading
Align Technology (NASDAQ:ALGN) Price Target Cut to $479.00
What 5 Analyst Ratings Have To Say About Align Tech
Are Investors Repeating Mistakes They Made in 2020?
5 Worst Performing S&P 500 Stocks in April
10 Stocks to Watch on Thursday
See More Headlines

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ALGN
CUSIP
01625510
Employees
22,540
Year Founded
1997

Company Calendar

Last Earnings
4/27/2022
Today
7/06/2022
Next Earnings (Confirmed)
7/27/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$586.20
High Stock Price Forecast
$810.00
Low Stock Price Forecast
$418.00
Forecasted Upside/Downside
+132.1%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
11 Analysts

Profitability

Net Income
$772.02 million
Pretax Margin
23.28%

Debt

Sales & Book Value

Annual Sales
$3.95 billion
Cash Flow
$11.41 per share
Book Value
$45.94 per share

Miscellaneous

Free Float
78,302,000
Market Cap
$19.91 billion
Optionable
Optionable
Beta
1.77

Social Links















Align Technology Frequently Asked Questions

Should I buy or sell Align Technology stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Align Technology stock.
View analyst ratings for Align Technology
or view top-rated stocks.

What is Align Technology's stock price forecast for 2022?

11 brokerages have issued 1-year price targets for Align Technology's stock. Their ALGN stock forecasts range from $418.00 to $810.00. On average, they anticipate Align Technology's stock price to reach $586.20 in the next year. This suggests a possible upside of 132.7% from the stock's current price.
View analysts' price targets for Align Technology
or view top-rated stocks among Wall Street analysts.

How has Align Technology's stock performed in 2022?

Align Technology's stock was trading at $657.18 on January 1st, 2022. Since then, ALGN shares have decreased by 61.7% and is now trading at $251.89.
View the best growth stocks for 2022 here
.

When is Align Technology's next earnings date?

Align Technology is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for Align Technology
.

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) issued its earnings results on Wednesday, April, 27th. The medical equipment provider reported $1.70 EPS for the quarter, missing analysts' consensus estimates of $1.99 by $0.29. The medical equipment provider earned $973.22 million during the quarter, compared to analyst estimates of $1 billion. Align Technology had a trailing twelve-month return on equity of 19.90% and a net margin of 17.51%. During the same quarter last year, the company earned $2.51 earnings per share.
View Align Technology's earnings history
.

Who are Align Technology's key executives?

Align Technology's management team includes the following people:

What is Joe Hogan's approval rating as Align Technology's CEO?

346 employees have rated Align Technology CEO Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among Align Technology's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), Salesforce (CRM), Mastercard (MA) and Tesla (TSLA).

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

How do I buy shares of Align Technology?

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Align Technology's stock price today?

One share of ALGN stock can currently be purchased for approximately $251.89.

How much money does Align Technology make?

Align Technology (NASDAQ:ALGN) has a market capitalization of $19.85 billion and generates $3.95 billion in revenue each year. The medical equipment provider earns $772.02 million in net income (profit) each year or $8.89 on an earnings per share basis.

How many employees does Align Technology have?

Align Technology employs 22,540 workers across the globe.

Does Align Technology have any subsidiaries?

The following companies are subsidiares of Align Technology: Align Technology Switzerland GmbH, Cadent, G.L. Dental Couture, and exocad Global Holdings GmbH (“exocad”).
Read More

When was Align Technology founded?

Align Technology was founded in 1997.

How can I contact Align Technology?

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The official website for Align Technology is www.aligntech.com. The medical equipment provider can be reached via phone at (408) 470-1000, via email at align@ethoscommunication.com, or via fax at 408-470-1010.

This page (NASDAQ:ALGN) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.